bullish

Takeda Pharma (4502) - Strong Results

798 Views30 Jan 2025 14:33
Takeda Pharma announced decent results and an upward revision for the full year. On an accounting basis, the revision is big. On a real basis, less so, but still good. Then there's a ¥100bn buyback.
What is covered in the Full Insight:
  • Introduction
  • Takeda's Q3 Results and Revised Guidance
  • Share Buyback Announcement
  • Stock Performance and Valuation
  • Conclusion and Trading Considerations
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Related Insights
More »
    Loading
Trending Collections
More »
    Loading
Trending Insights
More »
    Loading
Top Unpaywalled Insights
More »
    Loading
Discussions
(Paid Plans Only)
chart-bar
Logo
Top 5%
Travis Lundy
Pan-Asia Catalysts/Events
Quiddity Advisors
Japan & Hong KongEquitiesEvent-DrivenQuantitative Analysis
Price Chart(Sign Up to Access)
analytics-chart
  • Loading...
x